BioChemics, D&O Insurer Battle Over SEC Subpoena Claim

Law360, New York (February 18, 2014, 4:33 PM EST) -- Axis Reinsurance Co. and BioChemics Inc. each urged a Massachusetts federal court Friday to grant summary judgment in a directors and officers coverage dispute over U.S. Securities and Exchange Commission subpoenas and an SEC enforcement action, debating whether the underlying claims were connected to claims made before an Axis policy took effect.

BioChemics and its former CEO, President and Chairman John Masiz argued in a renewed motion for partial summary judgment that Axis owed defense coverage for SEC subpoenas from 2012 and a December 2012 enforcement...
To view the full article, register now.